Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Ansar S, Koska J, Reaven PD (2011) Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins. Cardiovasc Diabetol. https://doi.org/10.1186/1475-2840-10-61
2. Bashary R, Vyas M, Nayak SK, Suttee A, Verma S, Narang R, Khatik GL (2020) An insight of alpha-amylase inhibitors as a valuable tool in the management of type 2 diabetes mellitus. Curr Diabetes Rev 16(2):117–136
3. Ceriello A (2005) Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54(1):1–7
4. Ćorković I, Gašo-Sokač D, Pichler A, Šimunović J, Kopjar M (2022) Dietary polyphenols as natural inhibitors of α-amylase and α-glucosidase. Life 12:1692
5. Demir Y, Durmaz L, Taslimi P, Gulçin İ (2019) Antidiabetic properties of dietary phenolic compounds: inhibition effects on α-amylase, aldose reductase, and α-glycosidase. Biotechnol Appl Biochem 66(5):781–786